doi: 10.1097/00005792-198507000-00007 11 ShieldsCGlassmanSLisaBESRaqueG
Many people who turn to compounded GLP-1 drugs do so without proper medical guidance, putting themselves at unnecessary risk
In partnership with Reuters , Truveta Research explored the percentage of patients who received a first-time diagnosis of type 2 diabetes, cardiovascular disease, or sleep apnea within 15 days of their first-time GLP-1 prescriptions
Nausea was the most common adverse event, significantly higher in the GLP-1RA group compared to placebo
Apply evidence-based dosing and titration protocols for semaglutide, tirzepatide, liraglutide, and peptides from day one
Intranasal products like the Synchronicity Health glutathione nasal spray provide a non-invasive way to raise glutathione levels and may reach the brain and upper respiratory tract